Skip to content

DoubleLine ETF Adviser LP: IFF position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of DoubleLine ETF Adviser LP on IFF, newest first. How the timeline and the estimate are built.

DoubleLine ETF Adviser LP held 0 IFF shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -29,547 shares

    13F-HR 0000929638-26-000663 filed by DoubleLine ETF Adviser LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 29,547 shares
    Change vs previous 13F +1,199 shares

    0.55% of the 13F portfolio, value $1,818,322.

    13F-HR 0000929638-25-004286 filed by DoubleLine ETF Adviser LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 28,348 shares
    Change vs previous 13F +28,348 shares

    0.67% of the 13F portfolio, value $2,084,995.

    13F-HR 0000929638-25-003060 filed by DoubleLine ETF Adviser LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -28,781 shares

    13F-HR 0000929638-25-001906 filed by DoubleLine ETF Adviser LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2024-12-31
    13F 28,781 shares
    Change vs previous 13F not available

    0.66% of the 13F portfolio, value $2,433,434.

    13F-HR 0000929638-25-000799 filed by DoubleLine ETF Adviser LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).